Determination of myocardial NF-κB and PPARG protein expression by Western blot analyses. A) Relative expression levels of activated NF-κB protein were determined using Western blot; the IA values were normalized to ACTB expression levels. Lanes a, b, c, d, e, and f in the representative gel show NF-κB expressions in the sham-operated, I/R, GW9662, telmisartan, telmisartan–GW9662, and candesartan groups, respectively. B) Relative expression levels of activated PPARG protein were determined using Western blot; the IA values were normalized to ACTB expression. Lanes a, b, c, d, e, and f in the representative gel show PPARG expression in the sham-operated, I/R, GW9662, telmisartan, telmisartan–GW9662, and candesartan groups, respectively. C) Quantitative analyses of the expression activated NF-κB protein. *P < 0.05 versus sham-operated group; #P < 0.05 versus I/R group. D) Quantitative analyses of the expression activated PPARG protein. *P < 0.05 compared with sham-operated; #P < 0.05 compared with I/R.